Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery


Postoperative atrial fibrillation (POAF) is a common complication after heart surgery. Amiodarone is the drug of choice to treat POAF. Inflammation is considered one of underlying factor for POAF. Minocycline is an antibiotic with anti-inflammatory properties.

Study Start Date

October 2011

Estimated Completion Date

March 2017


  • Drug: Amiodarone
  • Drug: Minocycline


  • Cardiology: Arrhythmias/EP,Cardiac Surgery,Clinical Pharmacology,Prevention
  • Surgery: Cardiac Surgery,Clinical Pharmacology,Patient Management
  • Anesthesiology: Cardiothoracic,Critical Care,Pharmacology/kinetics
  • Pharmacy: Cardiac/Hypertension,Drug Interactions,Drug Trials

MeSH Terms

  • Atrial Fibrillation
  • Cardiac Surgical Procedures

Study ID

Baystate Medical Center -- BH-09-176



Trial ID


Study Type


Trial Phase


Enrollment Quota



Baystate Medical Center

Inclusion Criteria

    -Eligibility criteria includes all non-congenital cardiac operations are included:
  • coronary artery bypass graft (CABG),
  • valve repair/replacement, or
  • combination of CABG and heart valve operations.

Exclusion Criteria

  • prior (within 6 months) or current PAF or flutter,
  • prior cerebrovascular event,
  • cardiogenic shock or resuscitation,
  • evidence of hepatic or renal dysfunctions (i.e., an alanine aminotransferase level that is >= twice the upper limit of the normal range, or either a serum creatinine level that is >= 2.0 mg/dL or need for preoperative dialysis),
  • thyrotoxicosis,
  • pregnancy,
  • severe COPD (FEV1/FVC <70%),
  • recent history of drug or alcohol abuse, and
  • intolerance to tetracycline or amiodarone. Finally, because a core scientific basis of the trial concerned the role of underlying atrial tissue inflammatory activity, patients with inflammatory conditions such as lupus, severe arthritis, thyroiditis or inflammatory bowel disease are excluded
  • as are patients taking preoperative immunosuppressant agents, long-term oral corticosteroids, or estrogen replacement and a newly diagnosed cancer (<5 years).




18 Years and older

Accepts Healthy Volunteers


Study Locations and Contact Information (2)

Study Location Distance Name Phone Email
Baystate Medical Center - Springfield, Massachusetts 78.8 miles None None None
Baystate Medical Center - Springfield, Massachusetts 78.8 miles Barbara Burkott BN BSNCCRP 413-794-0000 barbara.burkott@baystatehealth.org

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.